Literature DB >> 22473007

Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients.

Yasar Caliskan1, Abdullah Ozkok, Tulin Akagun, Nadir Alpay, Goksel Guz, Nihat Polat, Fatih Tufan, Tevfik Ecder, Semra Bozfakioglu.   

Abstract

BACKGROUND: We investigated the relationship among serum cardiac biomarkers including N-terminal pro-brain natriuretic peptide (NT-pro-BNP), cardiac troponin T (cTnT), uric acid and high-sensitive C-reactive protein (hs-CRP) and noninvasive predictors of atherosclerosis including carotid intima-media thickness (IMT), aortic stiffness (pulse wave velocity (PWV)) and transthoracic coronary flow reserve (CFR) in peritoneal dialysis (PD) patients.
METHODS: 37 PD patients were included in the study. We measured (1) carotid IMT, (2) PWV and augmentation index (AIx), and (3) CFR. Simultaneous measurements of serum NT-pro-BNP, cTnT, uric acid and hs-CRP were also performed. Associations among these variables were analyzed.
RESULTS: cTnT was significantly associated with carotid IMT (r = 0.747, p < 0.001), PWV (r = 0.431, p = 0.035) and CFR (r = -0.439, p = 0.007). In multivariate analysis, cTnT was a significant independent predictor of carotid IMT (β = 4.446, p < 0.001) and CFR (β = -2.272, p = 0.013). Patients with high cTnT levels (≥0.01 ng/ml) significantly hadhigher carotid IMT and PWV values. Only the aortic PWV significantly correlated with residual renal function (r = -0.574, p = 0.004).
CONCLUSIONS: Serum cTnT appeared to be a useful clinical biomarker for evaluating noninvasive predictors of atherosclerosis in chronic PD patients. Arterial stiffness as determined by PWV is also correlated with residual renal function.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22473007     DOI: 10.1159/000332084

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  7 in total

1.  The importance of residual renal function in peritoneal dialysis.

Authors:  Dorota Sikorska; Krzysztof Pawlaczyk; Anna Olewicz-Gawlik; Natasza Czepulis; Bartlomiej Posnik; Ewa Baum; Maria Wanic-Kossowska; Bengt Lindholm; Andrzej Oko
Journal:  Int Urol Nephrol       Date:  2016-10-12       Impact factor: 2.370

2.  Alteration of cardiovascular structure and function in patients undergoing peritoneal dialysis.

Authors:  Damir R Rebić; Senija R Rašić; Muamer D Dervišević; Aida H M Hamzić-Mehmedbašić; Alma M Muslimović; Edina H Hasanagić
Journal:  Cardiorenal Med       Date:  2015-03-25       Impact factor: 2.041

3.  Low serum adiponectin level is associated with central arterial stiffness in patients undergoing peritoneal dialysis.

Authors:  Ti-Kang Chen; Yu-Chien Pan; Chih-Hsien Wang; Jia-Sian Hou; Bang-Gee Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-08-02

4.  Nontraditional cardiovascular biomarkers and estimation of cardiovascular risk in predialysis chronic kidney disease patients and their correlations with carotid intima media thickness.

Authors:  Satyanand Sathi; Himanshu Mahapatra; Sham Sunder; Rajesh Jayaraman; Neera Sharma; Himanshu Verma; Venkataramanan Krishnamoorthy; Anurag Gupta; Prabhu Kanchi; Sunil Daksh; Lalit Pursnani; Faisal Shadab; Manveer Singh
Journal:  Nephrourol Mon       Date:  2014-11-11

5.  Radial augmentation index may be an effective predictor of vascular calcification in patients on peritoneal dialysis.

Authors:  Ning Yang; Wei Yang; Wenting Cui; Dan Zhou; Xiangning Du; Longkai Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

6.  The serum sclerostin level is positively associated with the aortic augmentation index in patients on peritoneal dialysis.

Authors:  Lin Lin; Yu-Hsien Lai; Liang-Te Chiu; Jen-Pi Tsai; Chih-Hsien Wang; Bang-Gee Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019 Apr-Jun

7.  Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults.

Authors:  Shuiqing Liu; Esther D Kim; Aozhou Wu; Michelle L Meyer; Susan Cheng; Ron C Hoogeveen; Christie M Ballantyne; Hirofumi Tanaka; Gerardo Heiss; Elizabeth Selvin; Kunihiro Matsushita
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.